Breaking News Instant updates and real-time market news.

MTUAY

MTU Aero Engines

$106.27 /

+0.27 (+0.25%)

19:44
02/07/22
02/07
19:44
02/07/22
19:44

MTU Aero Engines initiated with a Buy at Jefferies

Jefferies analyst Chloe Lemarie initiated coverage of MTU Aero Engines with a Buy rating and EUR 225 price target. The A&D sector is entering the first year of material recovery after its worst ever crisis, the analyst tells investors in a research note, adding that she is favoring cheaper stocks with margin-driven earnings upside and short-term catalysts. Lemarie adds that after the stock de-rated 15%, consensus expectations are not stretched on the name.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Biogen announces FDA accepted for review the aBLA for BIIB800 » 07:32
12/09/22
12/09
07:32
12/09/22
07:32
BIIB

Biogen

$289.00 /

-3.4 (-1.16%)

Biogen announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$289.00 /

-3.4 (-1.16%)

BIIB Biogen
$289.00 /

-3.4 (-1.16%)

12/02/22 JonesTrading
Anavex price target raised to $80 from $40 at JonesTrading
12/01/22 Atlantic Equities
Biogen price target raised to $295 from $220 at Atlantic Equities
11/30/22 Mizuho
Mizuho says Biogen not mentioned in 90 minute lecanemab presentation
11/30/22 Jefferies
Biogen price target raised to $350 from $325 at Jefferies
BIIB Biogen
$289.00 /

-3.4 (-1.16%)

BIIB Biogen
$289.00 /

-3.4 (-1.16%)

BIIB Biogen
$289.00 /

-3.4 (-1.16%)

BIIB Biogen
$289.00 /

-3.4 (-1.16%)

Initiation
Presto Automation initiated with a Neutral at Chardan » 07:32
12/09/22
12/09
07:32
12/09/22
07:32
PRST

Presto Automation

$3.97 /

+0.52 (+15.07%)

Chardan analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRST Presto Automation
$3.97 /

+0.52 (+15.07%)

Hot Stocks
Chart Industries announces pricing of upsized public offerings » 07:32
12/09/22
12/09
07:32
12/09/22
07:32
GTLS

Chart Industries

$118.05 /

-16.83 (-12.48%)

Chart Industries…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTLS Chart Industries
$118.05 /

-16.83 (-12.48%)

GTLS Chart Industries
$118.05 /

-16.83 (-12.48%)

11/29/22 Citi
Halliburton should take equity stake in Chart Industries, says Citi
11/22/22 Goldman Sachs
Chart Industries downgraded to Neutral from Buy at Goldman Sachs
11/18/22 Piper Sandler
Chart Industries downgraded on higher leverage at Piper Sandler
11/18/22 Piper Sandler
Chart Industries downgraded to Neutral from Overweight at Piper Sandler
GTLS Chart Industries
$118.05 /

-16.83 (-12.48%)

  • 09
    Dec
GTLS Chart Industries
$118.05 /

-16.83 (-12.48%)

Recommendations
Workday price target raised to $225 from $220 at Cowen » 07:31
12/09/22
12/09
07:31
12/09/22
07:31
WDAY

Workday

$169.39 /

+4.73 (+2.87%)

Cowen analyst J. Derrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WDAY Workday
$169.39 /

+4.73 (+2.87%)

WDAY Workday
$169.39 /

+4.73 (+2.87%)

12/05/22 Credit Suisse
Workday price target lowered to $195 from $215 at Credit Suisse
11/30/22 Deutsche Bank
Workday price target lowered to $215 from $230 at Deutsche Bank
11/30/22 Baird
Workday price target lowered to $223 from $235 at Baird
11/30/22 JPMorgan
Workday price target lowered to $223 from $235 at JPMorgan
WDAY Workday
$169.39 /

+4.73 (+2.87%)

WDAY Workday
$169.39 /

+4.73 (+2.87%)

WDAY Workday
$169.39 /

+4.73 (+2.87%)

Hot Stocks
Figure Acquisition Corp. I to merge with large warehouse lender, bank holding co » 07:31
12/09/22
12/09
07:31
12/09/22
07:31
FACA

Figure Acquisition Corp. I

$10.02 /

+ (+0.00%)

Figure Acquisition Corp.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Beyond Meat downgraded to Sell at Argus on declining demand, competition » 07:31
12/09/22
12/09
07:31
12/09/22
07:31
BYND

Beyond Meat

$16.16 /

+0.53 (+3.39%)

Argus analyst Kristina…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$16.16 /

+0.53 (+3.39%)

BYND Beyond Meat
$16.16 /

+0.53 (+3.39%)

07:25 Today Argus
Beyond Meat downgraded to Sell from Hold at Argus
11/28/22 Barclays
Beyond Meat downgraded to Underweight from Equal Weight at Barclays
11/23/22 Goldman Sachs
Beyond Meat price target lowered to $5 from $14 at Goldman Sachs
11/10/22 Bernstein
Beyond Meat price target lowered to $10 from $22 at Bernstein
BYND Beyond Meat
$16.16 /

+0.53 (+3.39%)

BYND Beyond Meat
$16.16 /

+0.53 (+3.39%)

BYND Beyond Meat
$16.16 /

+0.53 (+3.39%)

BYND Beyond Meat
$16.16 /

+0.53 (+3.39%)

Recommendations
Ciena price target raised to $76 from $71 at Cowen » 07:30
12/09/22
12/09
07:30
12/09/22
07:30
CIEN

Ciena

$51.83 /

+8.51 (+19.64%)

Cowen analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CIEN Ciena
$51.83 /

+8.51 (+19.64%)

CIEN Ciena
$51.83 /

+8.51 (+19.64%)

07:08 Today Citi
Ciena price target raised to $65 from $55 at Citi
06:19 Today Barclays
Ciena price target raised to $71 from $55 at Barclays
10/11/22 Evercore ISI
Ciena downgraded to In Line at Evercore ISI on risk to 2023 IT demand
10/11/22 Evercore ISI
Ciena downgraded to In Line from Outperform at Evercore ISI
CIEN Ciena
$51.83 /

+8.51 (+19.64%)

CIEN Ciena
$51.83 /

+8.51 (+19.64%)

CIEN Ciena
$51.83 /

+8.51 (+19.64%)

Downgrade
Lululemon removed from Conviction Buy list at Goldman on tough comps » 07:28
12/09/22
12/09
07:28
12/09/22
07:28
LULU

Lululemon

$375.51 /

+2.84 (+0.76%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LULU Lululemon
$375.51 /

+2.84 (+0.76%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

07:24 Today Goldman Sachs
Lululemon downgraded to Buy from Conviction Buy at Goldman Sachs
06:55 Today Baird
Lululemon price target raised to $435 from $430 at Baird
06:18 Today UBS
Lululemon price target lowered to $390 from $395 at UBS
06:08 Today Piper Sandler
Lululemon price target raised to $390 from $350 at Piper Sandler
LULU Lululemon
$375.51 /

+2.84 (+0.76%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

Downgrade
Lululemon downgraded to Buy from Conviction Buy at Goldman Sachs » 07:24
12/09/22
12/09
07:24
12/09/22
07:24
LULU

Lululemon

$375.51 /

+2.84 (+0.76%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LULU Lululemon
$375.51 /

+2.84 (+0.76%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

06:55 Today Baird
Lululemon price target raised to $435 from $430 at Baird
06:18 Today UBS
Lululemon price target lowered to $390 from $395 at UBS
06:08 Today Piper Sandler
Lululemon price target raised to $390 from $350 at Piper Sandler
12/07/22 Deutsche Bank
Lululemon price target raised to $450 from $434 at Deutsche Bank
LULU Lululemon
$375.51 /

+2.84 (+0.76%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

Syndicate
ObsEva files $100M mixed securities shelf  07:24
12/09/22
12/09
07:24
12/09/22
07:24
OBSV

ObsEva

/

+

 
ShowHide Related Items >><<
OBSV ObsEva
/

+

OBSV ObsEva
/

+

08/30/22 H.C. Wainwright
ObsEva downgraded to Neutral from Buy at H.C. Wainwright
07/29/22 Canaccord
ObsEva cut to Hold at Canaccord as company goes 'back to square one'
07/29/22 Canaccord
ObsEva downgraded to Hold from Buy at Canaccord
07/28/22 Cantor Fitzgerald
ObsEva downgraded to Neutral from Overweight at Cantor Fitzgerald
OBSV ObsEva
/

+

Syndicate
Aptorum Group offers to sell $3M in convertible notes due 2023  07:24
12/09/22
12/09
07:24
12/09/22
07:24
APM

Aptorum Group

/

+

 
ShowHide Related Items >><<
APM Aptorum Group
/

+

APM Aptorum Group
/

+

11/03/22 Argus
Argus sets $9 fair value estimate for Aptorum in 'Sponsored Research' report
10/07/22 H.C. Wainwright
Aptorum Group initiated with a Buy at H.C. Wainwright
Downgrade
GMS Inc. downgraded to Hold at Loop Capital on valuation » 07:21
12/09/22
12/09
07:21
12/09/22
07:21
GMS

GMS Inc.

$55.00 /

+5.635 (+11.42%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

07:05 Today Baird
GMS Inc. price target raised to $67 from $56 at Baird
06:10 Today Loop Capital
GMS Inc. downgraded to Hold from Buy at Loop Capital
09/07/22 Truist
Truist cuts GMS Inc. to Hold on impact from downturn in residential construction
09/07/22 Truist
GMS Inc. downgraded to Hold from Buy at Truist
GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

Recommendations
Stifel cuts Mirati price target to $73, says move lower 'overdone' » 07:20
12/09/22
12/09
07:20
12/09/22
07:20
MRTX

Mirati Therapeutics

$43.87 /

-5.79 (-11.66%)

Stifel analyst Benjamin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$43.87 /

-5.79 (-11.66%)

MRTX Mirati Therapeutics
$43.87 /

-5.79 (-11.66%)

07:06 Today Citi
Mirati Therapeutics downgraded to Neutral from Buy at Citi (yesterday)
12/08/22 BofA
Mirati Therapeutics price target lowered to $61 from $100 at BofA
12/08/22 JPMorgan
Mirati Therapeutics downgraded to Neutral from Overweight at JPMorgan
12/08/22 Oppenheimer
Mirati Therapeutics price target lowered to $60 from $85 at Oppenheimer
MRTX Mirati Therapeutics
$43.87 /

-5.79 (-11.66%)

MRTX Mirati Therapeutics
$43.87 /

-5.79 (-11.66%)

MRTX Mirati Therapeutics
$43.87 /

-5.79 (-11.66%)

Upgrade
Pinduoduo upgraded to Outperform from Neutral at KGI Securities » 07:16
12/09/22
12/09
07:16
12/09/22
07:16
PDD

Pinduoduo

$91.11 /

+5.32 (+6.20%)

KGI Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDD Pinduoduo
$91.11 /

+5.32 (+6.20%)

PDD Pinduoduo
$91.11 /

+5.32 (+6.20%)

11/30/22 Barclays
Pinduoduo price target raised to $84 from $70 at Barclays
11/29/22 Benchmark
Pinduoduo price target raised to $112 from $107 at Benchmark
11/29/22 Morgan Stanley
Pinduoduo price target raised to $77 from $65 at Morgan Stanley
11/29/22 HSBC
Pinduoduo price target raised to $100 from $93 at HSBC
PDD Pinduoduo
$91.11 /

+5.32 (+6.20%)

PDD Pinduoduo
$91.11 /

+5.32 (+6.20%)

PDD Pinduoduo
$91.11 /

+5.32 (+6.20%)

PDD Pinduoduo
$91.11 /

+5.32 (+6.20%)

Hot Stocks
Just Energy announces delisting, trading halt dates » 07:16
12/09/22
12/09
07:16
12/09/22
07:16
JENGQ

Just Energy

$1.74 /

+ (+0.00%)

Just Energy Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JENGQ Just Energy
$1.74 /

+ (+0.00%)

Recommendations
Oric Pharmaceuticals added to Analyst Focus List at JPMorgan » 07:14
12/09/22
12/09
07:14
12/09/22
07:14
ORIC

Oric Pharmaceuticals

$3.23 /

-0.13 (-3.87%)

JPMorgan analyst Anupam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORIC Oric Pharmaceuticals
$3.23 /

-0.13 (-3.87%)

ORIC Oric Pharmaceuticals
$3.23 /

-0.13 (-3.87%)

07/15/22 Oppenheimer
Oric Pharmaceuticals assumed with a Perform at Oppenheimer
04/04/22 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/22 H.C. Wainwright
Oric Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
03/22/22 Guggenheim
Oric downgraded to Neutral at Guggenheim after ORIC-101 discontinuation
ORIC Oric Pharmaceuticals
$3.23 /

-0.13 (-3.87%)

Recommendations
Zions Bancorp price target lowered to $57 from $60 at Truist » 07:13
12/09/22
12/09
07:13
12/09/22
07:13
ZION

Zions Bancorp

$47.39 /

+0.32 (+0.68%)

Truist analyst Jennifer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZION Zions Bancorp
$47.39 /

+0.32 (+0.68%)

ZION Zions Bancorp
$47.39 /

+0.32 (+0.68%)

12/05/22 Morgan Stanley
Zions Bancorp initiated with an Equal Weight at Morgan Stanley
11/03/22 Wolfe Research
Wolfe downgrades Zions, Cullen/Frost to neutral after outperformance
11/02/22 Wolfe Research
Zions Bancorp downgraded to Peer Perform from Outperform at Wolfe Research
10/25/22 DA Davidson
Zions Bancorp price target lowered to $56 from $61 at DA Davidson
ZION Zions Bancorp
$47.39 /

+0.32 (+0.68%)

ZION Zions Bancorp
$47.39 /

+0.32 (+0.68%)

Recommendations
Wintrust Financial price target lowered to $102 from $112 at Truist » 07:13
12/09/22
12/09
07:13
12/09/22
07:13
WTFC

Wintrust Financial

$87.10 /

-0.28 (-0.32%)

Truist analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WTFC Wintrust Financial
$87.10 /

-0.28 (-0.32%)

WTFC Wintrust Financial
$87.10 /

-0.28 (-0.32%)

10/20/22 RBC Capital
Wintrust Financial price target raised to $115 from $109 at RBC Capital
10/20/22 Truist
Wintrust Financial price target raised to $112 from $100 at Truist
10/20/22 Raymond James
Wintrust Financial price target raised to $118 from $111 at Raymond James
10/20/22 Piper Sandler
Wintrust Financial price target raised to $121 from $107 at Piper Sandler
WTFC Wintrust Financial
$87.10 /

-0.28 (-0.32%)

  • 08
    Jun
Recommendations
South State price target lowered to $96 from $103 at Truist » 07:13
12/09/22
12/09
07:13
12/09/22
07:13
SSB

South State

$80.78 /

-0.66 (-0.81%)

Truist analyst Jennifer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSB South State
$80.78 /

-0.66 (-0.81%)

SSB South State
$80.78 /

-0.66 (-0.81%)

09/28/22 Piper Sandler
South State upgraded to Overweight from Neutral at Piper Sandler
08/01/22 Truist
South State price target raised to $97 from $90 at Truist
06/15/22 Truist
South State price target lowered to $90 from $92 at Truist
06/02/22 Keefe Bruyette
South State upgraded to Outperform from Market Perform at Keefe Bruyette
SSB South State
$80.78 /

-0.66 (-0.81%)

SSB South State
$80.78 /

-0.66 (-0.81%)

Recommendations
SVB Financial price target lowered to $250 from $274 at Truist » 07:13
12/09/22
12/09
07:13
12/09/22
07:13
SIVB

SVB Financial

$222.71 /

+14.44 (+6.93%)

Truist analyst Jennifer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIVB SVB Financial
$222.71 /

+14.44 (+6.93%)

SIVB SVB Financial
$222.71 /

+14.44 (+6.93%)

12/07/22 Piper Sandler
SVB Financial price target lowered to $220 from $265 at Piper Sandler
12/05/22 Morgan Stanley
SVB Financial downgraded to Underweight from Equal Weight at Morgan Stanley
12/05/22 Morgan Stanley
Silvergate Capital downgraded to Underweight from Equal Weight at Morgan Stanley
12/01/22 Wolfe Research
SVB Financial price target lowered to $235 from $315 at Wolfe Research
SIVB SVB Financial
$222.71 /

+14.44 (+6.93%)

SIVB SVB Financial
$222.71 /

+14.44 (+6.93%)

SIVB SVB Financial
$222.71 /

+14.44 (+6.93%)

Recommendations
Pinnacle Financial price target lowered to $90 from $96 at Truist » 07:12
12/09/22
12/09
07:12
12/09/22
07:12
PNFP

Pinnacle Financial

$76.11 /

+0.76 (+1.01%)

Truist analyst Jennifer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNFP Pinnacle Financial
$76.11 /

+0.76 (+1.01%)

PNFP Pinnacle Financial
$76.11 /

+0.76 (+1.01%)

10/20/22 Wells Fargo
Pinnacle Financial price target lowered to $100 from $105 at Wells Fargo
10/06/22 Raymond James
Pinnacle Financial downgraded to Market Perform from Outperform at Raymond James
07/11/22 Jefferies
Jefferies downgrades Pinnacle Financial to sell into possible recession
07/11/22 Jefferies
Pinnacle Financial downgraded to Underperform from Hold at Jefferies
PNFP Pinnacle Financial
$76.11 /

+0.76 (+1.01%)

Recommendations
Live Oak Bancshares price target lowered to $38 from $40 at Truist » 07:12
12/09/22
12/09
07:12
12/09/22
07:12
LOB

Live Oak Bancshares

$32.34 /

-0.48 (-1.46%)

Truist analyst Jennifer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LOB Live Oak Bancshares
$32.34 /

-0.48 (-1.46%)

LOB Live Oak Bancshares
$32.34 /

-0.48 (-1.46%)

10/31/22 Truist
Live Oak Bancshares price target lowered to $40 from $45 at Truist
09/28/22 Piper Sandler
Live Oak Bancshares price target lowered to $35 from $40 at Piper Sandler
09/14/22 Truist
Live Oak Bancshares price target lowered to $45 from $55 at Truist
08/15/22 Truist
Live Oak Bancshares price target raised to $55 from $45 at Truist
LOB Live Oak Bancshares
$32.34 /

-0.48 (-1.46%)

Recommendations
Ecolab price target raised to $180 from $175 at JPMorgan » 07:11
12/09/22
12/09
07:11
12/09/22
07:11
ECL

Ecolab

$149.15 /

+1.14 (+0.77%)

JPMorgan analyst Jeffrey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECL Ecolab
$149.15 /

+1.14 (+0.77%)

ECL Ecolab
$149.15 /

+1.14 (+0.77%)

12/02/22 Barclays
Ecolab downgraded to Equal Weight from Overweight at Barclays
11/03/22 BMO Capital
Ecolab price target lowered to $143 from $169 at BMO Capital
11/02/22 Deutsche Bank
Deutsche Bank downgrades Ecolab, says valuation premium 'too high'
11/02/22 Deutsche Bank
Ecolab downgraded to Hold from Buy at Deutsche Bank
ECL Ecolab
$149.15 /

+1.14 (+0.77%)

ECL Ecolab
$149.15 /

+1.14 (+0.77%)

Recommendations
Independent Bank price target lowered to $70 from $74 at Truist » 07:11
12/09/22
12/09
07:11
12/09/22
07:11
IBTX

Independent Bank

$63.26 /

+0.455 (+0.72%)

Truist analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IBTX Independent Bank
$63.26 /

+0.455 (+0.72%)

IBTX Independent Bank
$63.26 /

+0.455 (+0.72%)

10/26/22 Truist
Independent Bank price target lowered to $74 from $80 at Truist
10/26/22 Hovde Group
Independent Bank downgraded to Market Perform from Outperform at Hovde Group
09/16/22 Piper Sandler
Independent Bank price target lowered to $75 from $78 at Piper Sandler
07/06/22 Truist
Independent Bank price target lowered to $76 from $85 at Truist
IBTX Independent Bank
$63.26 /

+0.455 (+0.72%)

Recommendations
Equifax price target raised to $222 from $181 at Stifel » 07:11
12/09/22
12/09
07:11
12/09/22
07:11
EFX

Equifax

$198.11 /

+4.08 (+2.10%)

Stifel analyst Shlomo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EFX Equifax
$198.11 /

+4.08 (+2.10%)

EFX Equifax
$198.11 /

+4.08 (+2.10%)

12/02/22 Barclays
Equifax price target raised to $230 from $225 at Barclays
11/25/22 Baird
Equifax price target raised to $223 from $199 at Baird
11/15/22 Atlantic Equities
Equifax upgraded to Overweight from Neutral at Atlantic Equities
11/14/22 Needham
Equifax price target raised to $230 from $190 at Needham
EFX Equifax
$198.11 /

+4.08 (+2.10%)

EFX Equifax
$198.11 /

+4.08 (+2.10%)

EFX Equifax
$198.11 /

+4.08 (+2.10%)

EFX Equifax
$198.11 /

+4.08 (+2.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.